Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wen‐Jia Zuo
Observed names:
Wen-Jia Zuo,
Wen-jia Zuo,
Wenjia Zuo,
Zuo, Wen-Jia
Institution:
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Cancer Institute
ORCID:
0009-0004-6185-2319
Observed ORCID:
0009-0004-6185-2319
OpenAlex ID:
A5013085664
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
2019
·
Yi-Zhou Jiang
, Ding Ma
, et al.
·
Cancer Cell
·
1,151
PDF
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
2020
·
Yi-Zhou Jiang
, Yin Liu
, et al.
·
Cell Research
·
330
PDF
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
2016
·
Yi-Rong Liu
, Yi-Zhou Jiang
, et al.
·
Breast Cancer Research
·
249
PDF
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
2018
·
Li Chen
, Liu Yang
, et al.
·
Nature Communications
·
178
PDF
Molecular subtypes and precision treatment of triple-negative breast cancer
2020
·
Shen Zhao
, Wen-Jia Zuo
, et al.
·
Annals of Translational Medicine
·
147
PDF
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation
2019
·
Xi Jin
, Xiao-En Xu
, et al.
·
Science Advances
·
141
An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy
2014
·
Xiao-Jian Ni
, Xiao-Lan Zhang
, et al.
·
PLoS ONE
·
116
PDF
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression
2018
·
Yi-Zi Zheng
, Meng-Zhu Xue
, et al.
·
Cancer Research
·
97
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial
2023
·
Yin Liu
, Xiu-Zhi Zhu
, et al.
·
Cell Research
·
84
PDF
Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
2016
·
Wen-Jia Zuo
, Yi-Zhou Jiang
, et al.
·
Clinical Cancer Research
·
80
GATA3 mutations define a unique subtype of luminal‐like breast cancer with improved survival
2014
·
Yi‐Zhou Jiang
, Ke‐Da Yu
, et al.
·
Cancer
·
76
Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement
2021
·
Yin Liu
, Min He
, et al.
·
Frontiers in Oncology
·
67
PDF
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial
2025
·
Song-Yang Wu
, Xi Jin
, et al.
·
Nature Medicine
·
58
The advance of adjuvant treatment for triple-negative breast cancer
2021
·
Jingyu Ge
, Wenjia Zuo
, et al.
·
Cancer Biology and Medicine
·
51
Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma
2017
·
Jun Zhu
, Hao Wen
, et al.
·
PLoS ONE
·
44
PDF
The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis
2020
·
Shibin Cai
, Wenjia Zuo
, et al.
·
Frontiers in Oncology
·
35
PDF
Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival
2018
·
Ying Zhang
, Yajie Ji
, et al.
·
Breast Cancer Research and Treatment
·
29
Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
2018
·
Jian-wei Li
, Wen-jia Zuo
, et al.
·
Breast Cancer Research and Treatment
·
27
Transcriptome analysis of luminal breast cancer reveals a role for LOL in tumor progression and tamoxifen resistance
2019
·
Wei Sun
, Xiaoen Xu
, et al.
·
International Journal of Cancer
·
25
PDF
Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study
2015
·
Xi-Yu Liu
, Yi-Zhou Jiang
, et al.
·
Medicine
·
25
PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis
2014
·
Zhi-Ming Shao
, Yi-Rong Liu
, et al.
·
OncoTargets and Therapy
·
25
PDF
Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant
2019
·
Min He
, Jun‐Jie Li
, et al.
·
Cancer Medicine
·
20
PDF
Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial
2024
·
Wen-Jia Zuo
, Li Chen
, et al.
·
Therapeutic Advances in Medical Oncology
·
13
Immediate Postmastectomy Breast Reconstruction Showed Limited Advantage in Patient Survival after Stratifying by Family Income
2013
·
Yi-Zhou Jiang
, Yi-Rong Liu
, et al.
·
PLoS ONE
·
11
PDF
Serum HER2 levels predict treatment efficacy and prognosis in patients with HER2-positive breast cancer undergoing neoadjuvant treatment
2021
·
Wen-Jia Zuo
, Min He
, et al.
·
Gland Surgery
·
10
PDF
Show more works
View as search
Works count:
47
Citation count:
3,107
H-index:
21
I10-index:
25
Year
Topic
Type
